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ABSTRACT 
Voluntary surface electromyography (sEMG) amplitude is known to be influenced by 
both electrode position and subcutaneous adipose tissue thickness, and these factors likely 
compromise both between- and within-individual comparisons. Normalization of voluntary 
sEMG amplitude to evoked maximum M-wave parameters [MMAX peak-to-peak (P-P) and Area] 
may remove the influence of electrode position and subcutaneous tissue thickness. The purpose 
of this study was to: (i) assess the influence of electrode position on voluntary, evoked (MMAX 
P-P and Area) and normalized sEMG measurements across the surface of the vastus lateralis 
(VL; experiment 1: n=10); and (ii) investigate if MMAX normalization removed the confounding 
influence of subcutaneous tissue thickness [muscle-electrode distance (MED) from ultrasound 
imaging] on sEMG amplitude (experiment 2; n=41). Healthy young men performed maximum 
voluntary contractions (MVCs) and evoked twitch contractions during both experiments. 
Experiment 1: voluntary sEMG during MVCs was influenced by electrode location (P≤0.046, 
ES≥1.49 “large”), but when normalized to MMAX P-P showed no differences between VL sites 
(P=0.929) which was not the case when normalized to MMAX Area (P<0.004). Experiment 2: 
voluntary sEMG amplitude was related to MED, which explained 31-38% of the variance. 
Normalization of voluntary sEMG amplitude to MMAX P-P or MMAX Area reduced but did not 
consistently remove the influence of MED which still explained up to 16% (MMAX P-P) and 
23% (MMAX Area) of the variance. In conclusion, MMAX P-P was the better normalization 
parameter for removing the influence of electrode location and substantially reduced but did 
not consistently remove the influence of subcutaneous adiposity.  
Key Words 
sEMG; sEMG Normalization; Maximal m-wave; Spatial location; Muscle-Electrode 
Distance.  
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INTRODUCTION 
 
Surface electromyography (sEMG) is used for a range of important applications within 
physiology and biomechanics, including measurement of neuromuscular activation 1 and 
detection of neuromuscular disorders 2. In these different contexts, sEMG amplitude is often 
employed to assess the changes within individuals and/or the differences between individuals. 
However, the influence of a range of both extrinsic (e.g. electrode position) and intrinsic (e.g. 
subcutaneous fat) factors can confound sEMG measurements 1 and may compromise both 
between- and within-individual comparisons.  
Voluntary sEMG amplitude is known to vary with electrode location across the surface 
of a muscle 3–5 and thus even minor differences in placement (between-days or -researchers) 
may influence sEMG measurements. In addition, intrinsic factors such as subcutaneous fat 
thickness can also influence the measurement of sEMG amplitude during voluntary 
contractions. Specifically, muscle-electrode distance (MED) has been found to be inversely 
related to sEMG amplitude 6–8 due to the high electrical resistance of adipose tissue 8. It is 
currently unknown if evoked sEMG responses vary with electrode location and MED in a 
similar way to voluntary sEMG amplitude. If this were the case then normalization of voluntary 
sEMG amplitude to evoked responses may remove the influence of electrode location and 
MED, but this has not been investigated. 
The use of an evoked supra-maximal compound muscle action potential (MMAX) has 
emerged as a promising way of normalizing sEMG amplitude during voluntary contractions 
due to the highly controlled and involuntary nature of MMAX. Furthermore, MMAX may be 
particularly useful as an independent reference for normalisation of sEMG during maximum 
voluntary isometric contractions (MVCs); given that the most widely used voluntary reference 
task (MVCs) are not valid in this case (i.e. a variable normalized to itself) 9,10. Both MMAX 
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amplitude (i.e. peak-to-peak, MMAX P-P) and area (MMAX Area), which is dependent on both 
amplitude and duration of the evoked potentials 11, have been suggested/used as reference 
normalization measurements for voluntary sEMG 9,10,12,13. Although MMAX normalization of 
voluntary sEMG has been demonstrated to reduce between-participant variability 9 it is 
currently unknown if MMAX normalization of voluntary EMG recordings: (1) removes the 
influence of electrode location across the surface of the muscle on voluntary sEMG amplitude, 
and (2) removes the influence of MED on voluntary sEMG amplitude between-participants. 
Therefore, the first purpose of this study was to assess the influence of electrode 
positioning on voluntary and evoked sEMG amplitude [root mean square (RMS) during MVC; 
and MMAX P-P and Area], and the proportionality of these measures, using multiple recording 
sites across the surface of the vastus lateralis (VL) (experiment 1). The second purpose was to 
investigate if MMAX normalization removed the confounding influence of body fat, measured 
as MED (via 2D ultrasonography), on sEMG amplitude during MVCs (experiment 2). Our first 
hypothesis was that voluntary sEMG and MMAX P-P and Area would change in proportion 
across the surface of the VL, thus, normalized voluntary sEMG amplitude (to MMAX) would 
remove the confounding effect of electrode location. Our second hypothesis was that MMAX 
normalization would remove the inverse relationship between voluntary surface EMG 
amplitude and MED. 
 
MATERIALS AND METHODS 
 
Participants 
Healthy, recreationally active, young males with no previous lower-body injuries and 
no systematic strength training participation for >12 months took part in both experiments. 
Experiment one: n=10; age, 22 ± 2 y; height, 1.78 ± 0.07 m; body mass, 73 ± 5 kg; body mass 
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index, 24 ± 2 kg/m2. Experiment two: n=41; age, 24 ± 2 y; height, 1.76 ± 0.06 m; body mass, 
69 ± 6 kg; body mass index, 22 ± 1 kg/m2. The Loughborough University Ethics committee 
approved both experiments and participants provided written informed consent prior to their 
participation. 
 
Overview 
Participants reported for three laboratory sessions at a consistent time of day for both 
experiment one (sessions 3-6 days apart) and experiment two (sessions 7-10 days apart) and 
were instructed to avoid strenuous exercise in the 48 h prior to each session. In each experiment, 
the first laboratory session was used as familiarisation, followed by two main measurement 
sessions. All sessions involved isometric voluntary and evoked twitch contractions of the 
dominant knee extensors whilst seated in a rigid custom-built adjustable testing chair with knee 
and hip joint angles as follows: experiment 1, knee joint angle = 80°, hip joint angle = 54°; 
experiment 2, knee joint angle = 65°, hip joint angle = 54° (where 0° is full extension). The 
main measurement sessions involved a series of brief sub-maximum warm-up contractions 
followed by MVCs and evoked twitch contractions (via transcutaneous femoral nerve 
stimulation). During the main measurement sessions, sEMG recordings were made from six 
recording sites across the surface of the VL (Experiment 1) or from a single recording site over 
each of the superficial quadriceps [VL, vastus medialis (VM), rectus femoris (RF); Experiment 
2]. Experiment 2 also involved B-mode ultrasound measurements of MED at each of the sEMG 
recording sites over the individual quadriceps muscles, whilst participants were at rest in the 
testing apparatus. 
 
Recording Procedures 
Torque and sEMG recordings 
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Participants were securely strapped to the rigid isometric testing chair at the waist and 
across the chest to minimise extraneous bodily movement during all tasks. Force production 
was measured with a calibrated S-beam strain-gauge (linear range from 0-1500N, Force Logic, 
Swallowfield, UK). The strain gauge was attached to the participant using a custom reinforced 
non-extendable webbing strap (35 mm width) fastened ~3 cm superior to the lateral malleolus 
perpendicular to the participant’s lower leg. Force was sampled and recorded at 2,000 Hz using 
an analogue-to-digital (A/D) converter (Micro 1401, CED, Cambridge, UK) and PC utilising 
Spike 2 software (CED, Cambridge, UK). The force signal was low-pass filtered at 500 Hz 
with a fourth-order zero-lag Butterworth, digital filter (baseline noise: <0.2 N) and then gravity 
correction was applied by subtracting baseline force, before multiplying by lever length (the 
distance between the knee joint centre and the middle of the webbed strap) to calculate torque 
values. 
Following skin preparation (shaving, abrading, and cleansing with 70% ethanol) single 
differential (bipolar) wireless Trigno Standard sEMG sensors (Trigno, Delsys, Inc., Boston, 
MA; 1-cm inter-electrode distance) were placed at set percentages of thigh length (distance 
from knee joint space to the greater trochanter) parallel to the presumed orientation of the 
underlying fibres. Trigno wireless sensors have a built-in system with reference sensors in the 
same electrode, hence, no ground electrode is necessary. Sensors were secured to the skin using 
adhesive interfaces. For experiment one six sensors, organised in two rows of three sensors 
[anterior (A) or posterior (P)], were attached over the VL. The two parallel rows of sEMG 
electrodes were aligned along the long axis of the muscle at ~30% (anterior row) and ~70% 
(posterior row; Fig. 1) of the distance between the superficial anterior and posterior borders of 
the VL, respectively. The anterior and posterior borders of the VL muscles were assessed by 
palpation whilst participants contracted their quadriceps muscle. Sensors were placed at set 
percentages of thigh length (lateral knee joint centre to greater trochanter) from the superior 
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border of the patella as follows: A1 (40%), P1 (45%), A2 (50%), P2 (55%), A3 (60%) and P3 
(65%; Fig. 1). These sites were chosen to avoid the confounding influence of the innervation 
zone, in the most distal region of the VL 4,14, on EMG signal amplitude 3,15. For experiment 
two, sEMG sensors were placed in the centre of each constituent muscle belly at the following 
percentages of thigh length above the superior border of the patellar as follows: RF (65%); VL 
(60%); and VM (35%). In both experiments, sEMG signals were amplified at source (x300; 
20-to 450-Hz bandwidth) before further amplification (overall effective gain, x909) and 
subsequently sampled at 2,000 Hz using the same external (A/D) converter and computer 
software as the force recordings. During offline analysis, the sEMG data were time aligned 
with the force signal (inherent 48-ms delay of sEMG signal). 
 
Protocol 
Maximal voluntary contractions 
Following a series of sub-maximum contractions performed at percentages of perceived 
maximum [50% (x3), 75% (x3), and 90% (x1)] participants completed 2 (experiment 1) or 4 
(experiment 2) MVCs. Participants were instructed to extend their knee by “pushing as hard as 
possible” for 3-5 s during MVCs with ≥30 s recovery between each effort. Biofeedback was 
provided after the first MVC by displaying a horizontal cursor on the torque-time curve, 
displayed on a computer monitor in front of the participant, to indicate the greatest torque 
produced and encourage participants to produce greater torque with subsequent attempts. 
Additionally, verbal encouragement was given during all MVCs trials. Maximum voluntary 
torque (MVT) was the highest instantaneous torque during the MVCs, and RMS sEMG for 
each sensor was measured during a 500 ms epoch around MVT (250 ms either side of MVT; 
EMGMVT), and absolute values from each individual sensor were then normalized to both the 
MMAX P-P and MMAX Area (see below) from the same sensor.   
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Evoked twitch contractions and MMAX recordings  
Transcutaneous femoral nerve stimulation was conducted, whilst the participant was 
voluntarily passive, by placing an anode (70 x 100 mm carbon rubber electrode; Electro-
Medical Supplies, Greenham, UK) over the greater trochanter and a cathode (10 mm diameter, 
protruding 20 mm from a 35 x 55 mm plastic base; Electro-Medical Supplies, Greenham, UK) 
over the femoral nerve in the femoral triangle region, both were coated in conductive gel. 
Electrical stimulation was delivered with a constant current variable voltage stimulator 
(DS7AH, Digitimer Ltd., Welwyn Garden City, UK). The cathode was sequentially 
repositioned until the optimum cathode position was identified (highest twitch response to a 
constant low current stimuli), before being secured with transpore tape. Incremental single 
pulse stimuli were delivered (every 10 s, 15-20 mA increments) until peak twitch force and the 
peak-to-peak amplitude of the compound motor unit action potential (M-wave) plateaued for 
all recorded EMG sites. At least two further increments were delivered to ensure the plateau 
had been reached. Then three supra-maximal stimuli were delivered (10-15 s between each 
stimulus) at a current of 150% of the plateau level to measure supramaximal twitch force and 
MMAX P-P and Area.  
Ultrasound Measurements (Experiment two only) 
An ultrasound scanner [Hitachi EUB-8500, Northamptonshire, UK, 5-10 MHz linear 
array transducer (EUP-L53L), scanning width 92 mm] was used to collect B-mode images of 
the thigh with the mid-point of the probe positioned over VL (60% of thigh length), RF (65% 
of thigh length) and VM (35% of thigh length). Ultrasound images were recorded by a 
computer with ezcap video capture software (via an S-video to USB converter). Images were 
collected whilst participants were at rest in the same isometric testing apparatus used to record 
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knee extension torque. MED was measured, using an open source Tracker software (version 
4.92, physlets.org/tracker), as the distance from the surface of the skin to the muscle fascia 
(Fig. 2). 
 
Statistical analysis 
For both experiments the data from the main measurement sessions (session 2 and 3, 
excluding familiarisation) were averaged to enhance the reliability of the measurements, and 
statistical analysis was completed using SPSS version 22 (IBM Corporation, Armonk, New 
York, USA). The significance level was set at P < 0.05 and data are reported as mean ± SD. 
Due to both experiments having duplicate main sessions a within-participant coefficient of 
variation between sessions (CVW; (SD/mean) x 100) for twitch peak, MVT and EMGMVT data 
was calculated. CVW was quantified for each sEMG site (both experiments) but for experiment 
one individual CVW values from each measurement site were averaged across all six VL sites 
to provide an overall representation of the within-participant reliability of VL sEMG 
parameters that were measured. In addition, paired t-tests were used to confirm that there were 
no differences between the main measurement sessions. For experiment 1, repeated measures 
general linear models (one-way ANOVA) were used to determine the effects of electrode 
position on voluntary, evoked, and normalized sEMG measures. When a main effect of 
electrode position was detected differences between recording sites were assessed using 
Bonferroni adjusted post-hoc tests. The standardized effect size (ES; Cohen`s d) are included 
and ES of < 0.2 was considered “trivial”, ≥ 0.2 to ≤ 0.49 “small”, ≥ 0.5 to ≤ 0.79 “moderate” 
and ≥ 0.8 “large” 16.  
For experiment 2, bivariate relationships between MED and the sEMG parameters 
(absolute and normalized) were assessed with Pearson’s product moment correlations. As there 
were significant bivariate relationships between EMGMVT and MED for all three muscles, this 
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relationship was fitted with a quadratic function, which provided the best fit for the relationship 
between EMGMVT and MED. This relationship was used to correct individual sEMG amplitude 
to MED measurements at that recording site. This involved summating the individual’s 
residual, in comparison to the cohort relationship with MED (e.g. sEMG amplitude vs. MED), 
with the group mean for sEMG amplitude 17. Between-participant coefficient of variation [CVB 
(SD/Mean*100)] was calculated for absolute EMGMVT as well as EMGMVT normalized to 
MMAX P-P and MMAX Area, and MED corrected EMGMVT for each of the 3 muscles.  
 
RESULTS 
 
Reliability 
For experiment 1, the mean CVW value of the six VL sensors was 15.1% for absolute 
EMGMVT, 20.7% for MMAX P-P, and 21.2% for MMAX Area respectively, with no differences 
detected between test sessions for any of these measurements (t(9)≥ -1.528, P≥ 0.139). For 
experiment 2, the range of CVW values of the 3 sites over the three superficial quadriceps (VM, 
VL, RF) were 14-17%, 14-16% and 14-19% for absolute EMGMVT, MMAX P-P, and MMAX Area, 
respectively (t(40)≥ -0.873, P≥ 0.383). 
Knee extension MVT torque presented a mean CVW value of 4.8% in experiment one 
and 2.9% in experiment two. Twitch peak torque presented an excellent CVW within 
experiment 1 (0.6%) and experiment 2 (6.3%). No differences were found between days in 
either experiment for MVT or Twitch peak torque (t(9)≥ -1.191 , P≥ 0.094 for experiment one 
and t(40)≥ -0.879, P≥ 0.111 for experiment two). 
 
Experiment one – Spatial Location 
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There were differences in absolute EMGMVT between the six recording sites over the 
VL (F2,45= 7.273, P< 0.003) with specific differences as follows: A1 and A2 > P2 and P3 
(Bonferroni P≤ 0.036, ES≥ 1.63 “large”); P1> P3 (P≤ 0.046, ES≥ 1.49 “large”). The recording 
site with the highest EMGMVT amplitude (A1) was 42% higher than the site with the lowest 
value (P3; Table 1). 
There were also differences in absolute MMAX P-P between sites (F2,45= 4.069, P= 
0.004) and post-hoc tests revealed that A1 was greater than P2 (Bonferroni P≥ 0.024, ES≥ 2.41 
“large”) and A2 showed a tendency to be greater than P2 (Bonferroni P= 0.070, ES= 2.33 
“large”; Fig. 3B) with a 51% difference between the highest and the lowest site (Table 1). 
Similarly, absolute MMAX Area presented differences between sites (F2,45= 4.529, P= 0.020) 
with A1 and P3 > P2 (Bonferroni P≤ 0.041, ES≥ 1.37 “large”; Fig. 3C), a tendency for A3 to 
be higher than P2 (Bonferroni P≤ 0.062, ES≥ 0.86 “large”) and for A1 to be higher than P1 
(Bonferroni P≤ 0.087, ES≥ 1.23 “large”) with an overall 49% difference between the sites with 
the highest and lowest MMAX Area values (Table 1). 
In contrast, EMGMVT normalized to MMAX P-P showed no differences between the sites 
of VL (F2,45= 0.731, P= 0.929; Fig. 4), and therefore was not confounded by electrode location. 
However, EMGMVT normalized to MMAX Area was different between the recording sites (up to 
35%; F2,45= 4.083, P= 0.004) and P3 was revealed to be smaller than A2 and P2 (Bonferroni 
P≤ 0.014, ES≥ 1.1 “large”). 
  
Experiment two – Subcutaneous tissue thickness 
As expected, there was an inverse relationship between absolute EMGMVT and MED 
for VM (r = -0.62, n= 41, P< 0.001), RF (r = -0.62, n= 41, P< 0.001) and VL (r = -0.68, n= 41, 
P< 0.001; Fig. 5A). Thus, MED explained 31% (VL) to 38% (VM & RF) of the variability in 
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EMGMVT. Similar correlations with MED were found for MMAX P-P [VM (r = -0.71, n= 41, P< 
0.001), RF (r= -0.45, n= 41, P< 0.001) and VL (r = -0.68, n= 41, P< 0.001)] and MMAX area 
[VM (r = -0.49, n= 41, P< 0.001), RF (r= -0.37, n= 41, P= 0.017) and VL (r = -0.43, n= 41, P< 
0.001)]. When EMGMVT was normalized to MMAX P-P there remained a relationship with MED 
for two of the three muscles, that was positive for the VM (r= 0.40, n= 41, P= 0.022, Fig.  5 C) 
and negative for the RF (r= -0.34, n= 41, P= 0.010), the exception being the VL where EMGMVT 
normalized to MMAX P-P was unrelated to MED (r= -0.25, n= 41, P= 0.106). Hence, while 
normalization of VL EMGMVT to MMAX P-P removed the influence of MED, VM and RF MED 
still accounted for 12-16% of the between-participant variability in normalized sEMG 
amplitude. When EMGMVT was normalized to MMAX Area a significant negative relationship 
remained for RF (r= -0.48, n= 41, P< 0.001) and VL (r= -0.44, n= 41, P< 0.010) with MED, 
but for the VM there was no relationship with MED (r= 0.15, n= 41, P= 0.330; Fig 5 B). 
Therefore, EMGMVT normalized to MMAX Area removed the influence of MED for the VM, but 
for the RF and VL MED still accounted for 19-23% of the between-participant variability in 
sEMG amplitude. 
Absolute EMGMVT had a mean CVB across the 3 muscles of 52.5% (VM 51.1%; RF 
44.0%; VL 62.1%) but after MED correction (EMGMVT corrected to MED) mean CVB was 
34.4% (VM 34.2%; RF 29.6%; VL 39.5%). Therefore, MED correction reduced the between-
participant variability by 35% (Table 2). The mean CVB of EMGMVT normalized by MMAX P-
P at 38.3% (VM 40.5%; RF 30.8%; VL 38.9%; Table 2) and EMGMVT normalized by MMAX 
Area at 41.6% (VM 44.4%; RF 36.2%; VL 44.2%; Table 2) were also lower than absolute 
EMGMVT, but greater than EMGMVT corrected to MED. 
 
DISCUSSION 
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The present study assessed the influence of electrode location and MED on voluntary 
absolute and normalized (to MMAX P-P and Area) sEMG measurements. Absolute voluntary 
sEMG measurements varied by up to 42% with electrode location over the surface of the VL 
muscle; however, when normalized to MMAX P-P, but not MMAX Area, there was no longer an 
effect of electrode location. As expected, voluntary sEMG amplitude for each of the 3 muscles 
was moderately correlated with MED (largely subcutaneous fat), which explained 31-38% of 
the variance in EMGMVT. Normalization of voluntary sEMG to MMAX parameters reduced but 
did not consistently remove the variance explained by MED (P-P up to 16%, Area up to 23%), 
Thus, MMAX P-P was the better normalization parameter, that removed the influence of 
electrode location and reduced but did not consistently or fully remove the influence of 
adiposity.  
 
Electrode location 
EMGMVT varied across the surface of the VL, being as much as 42% higher at some 
sites compared to others. Previous investigations using the trapezius muscle have also found 
voluntary sEMG amplitude to vary with location over the surface of the muscle 18,19. MMAX P-
P showed a similar pattern to absolute voluntary EMG and consequently normalization of 
EMGMVT to MMAX P-P was independent of electrode location as both parameters changed 
proportionally across the surface of the VL. Hence this normalization method removed the 
effect of electrode location on voluntary sEMG amplitude. Furthermore, this finding suggests 
that any apparent differences in EMG amplitude across the surface of the muscle during MVCs 
are primarily due to differences in volume conduction and signal recording conditions, as 
shown by similar changes in MMAX P-P, rather than any physiological differences in voluntary 
neuromuscular activation. However, the current study did not examine sub-maximum 
contractions, thus the possibility of regional differences in neuromuscular activation during 
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low and moderate level contractions according to the specific task remains a distinct possibility 
20,21.  
In contrast, MMAX Area showed a different pattern to absolute voluntary sEMG, such 
that when EMGMVT was normalized to MMAX Area there remained a pronounced effect of 
electrode location with differences between sites of up to 57%. Therefore, MMAX P-P 
normalization may be preferred when trying to remove/account for the issue of electrode 
location/re-location between test sessions or between investigators. Normalisation to MMAX P-
P could theoretically have removed/reduced the influence of several between site confounding 
factors that may influence EMGMVT, such as the amplitude of motor unit action potentials, 
adipose tissue thickness, skin and skin-electrode interface impedance. Although experiment 1 
was not able to discriminate between these mechanisms by which MMAX P-P was effective. 
MMAX P-P qualitatively showed a similar pattern with electrode location as absolute 
voluntary sEMG, but not MMAX Area. The reason for these contrasting effects between MMAX 
P-P and Area, and thus also the greater efficacy of MMAX P-P for normalization purposes may 
reflect the differences in the nature of these measurements. MMAX P-P is a measure of amplitude, 
whereas MMAX Area is dependent on both amplitude and duration 11, thus our finding might 
indicate that absolute EMGMVT depends primarily on signal amplitude rather than duration. 
Previous studies have only examined spatial distribution of M-wave amplitude, during sub-
maximal stimulation and found the amplitude to be both higher 22 and lower at distal sites 23 in 
gastrocnemius. Sub-maximal stimulation selectively activates lower threshold motor units, and 
thus fibres, that could be concentrated in specific locations. In contrast, our findings are the 
first indication that MMAX P-P and Area vary with electrode location across the surface of the 
VL (albeit with different patterns). 
Although experiment 1 involved 6 electrodes over the surface of the VL muscle, we 
deliberately chose a large superficial muscle, and selected the measurement sites to minimise 
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the possibility of cross-talk from other muscles. Specifically, the measurement sites were a 
minimum of 3.5 cm distance, and typically >4 cm, from other muscles. Winter et al (1994) 
estimated that with a 3 cm distance between electrodes, cross-talk would account for ~4% of 
the signal 24. Therefore, it is possible that there could have been some small, limited cross-talk 
within our measurements, although our understanding is that there is no accepted analytical 
procedure to assess the extent of cross-talk within an EMG signal 26. 
 
Muscle-Electrode distance 
In experiment 2, there were negative relationships between EMGMVT and MED in all 
the three muscles (r = -0.56 to -0.62), with MED explaining 31-38% of the variance even within 
this relatively lean cohort (BMI≤ 24). Previous investigators identified similar negative 
relationships between absolute voluntary sEMG amplitude and MED measure by ultrasound (r 
= 0.57) 7 or skinfold thickness (r = 0.90 26 and r = 0.67 7). The relationship between absolute 
sEMG amplitude and MED can be explained by the high electrical resistance of body fat 8,27 
which acts as a low pass filter reducing the signal amplitude 28. Specifically, more subcutaneous 
tissue between the sEMG electrode and the muscle would provide more electrical resistance. 
Thus, tissue thickness between the electrode and the active muscle fibers has a pronounced 
influence on sEMG amplitude. 
MMAX normalization substantially reduced, but did not consistently remove the effect 
of MED on EMG amplitude with up to 16% (MMAX P-P) or 23% (MMAX Area) of the variability 
in normalized voluntary sEMG still explained by MED. Therefore, whilst MMAX normalization 
was certainly an improvement on absolute values it was only partially effective at removing 
the confounding effects of differences in MED between participants. Therefore, it is possible 
that a measured MED is more effective at fully removing the influence of adipose tissue 
thickness, than MMAX parameters when comparing participants. In addition, EMGMVT corrected 
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to MED produced lower between-participant variability (CVB 34%) than absolute EMGMVT 
(53%) or EMGMVT normalized to MMAX P-P (38%) or MMAX Area (42%) suggesting that MED 
correction may be the most effective method at reducing the between-participant variability 
introduced by volume conduction and signal recording conditions. Consequently, when 
comparing individuals with substantial differences in MED, or comparing repeated 
measurements that may involve changes in MED after an intervention (e.g. exercise training 
or weight loss) it is recommended to normalise voluntary sEMG measurements, either to MMAX 
P-P or preferably MED (e.g. 29). It is unclear why voluntary sEMG recordings and MMAX 
parameters do not change in proportion with MED, but it is likely to be due to the fact that 
voluntary sEMG is a summation pattern from the electrical activity of numerous muscle fibres 
2 that propagates through the surrounding tissues in a different manner to a synchronous evoked 
M-wave.  
Any variability in electrode location and orientation between participants could have 
been a contributory factor to the observed between-participant variability in voluntary sEMG 
recordings. Whilst the current investigation examined MED correction in relation to between-
participant variability in voluntary sEMG, as far as we are aware it is currently unknown how 
MED correction compares to MMAX normalisation for different electrode locations and future 
work should address this question to better understand the merits of these normalisation 
procedures. Moreover, it is recommended that future work more carefully examine the 
reliability and validity of voluntary sEMG amplitude measurements corrected to MED as this 
correction procedure has had relatively little attention despite the well-known confounding 
influence of adiposity 6–8. 
In conclusion, electrode location across the surface of the VL had a pronounced effect 
on voluntary sEMG amplitude during MVCs, and this was removed by normalization to MMAX 
P-P, but not MMAX Area. The moderate relationship between adiposity (MED) and voluntary 
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sEMG amplitude (R2=0.31 up to 0.38) was reduced but not consistently removed by MMAX 
normalization (up to R2= 0.16 [P-P] and R2= 0.23 [Area]). MMAX P-P was the better 
normalization parameter that removed the influence of electrode location and substantially 
reduced but did not consistently or fully remove the influence of adiposity. 
 
PERSPECTIVES 
Whilst surface electromyography (sEMG) measurements are widely used in 
physiological and biomechanical assessments and research studies, the amplitude of these 
recordings are known to be influenced by both electrode position and subcutaneous adipose 
tissue thickness. The present study quantified the influence of electrode position and adipose 
tissue thickness and examined the possibility that normalization to evoked maximum M-wave 
(MMAX) parameters may remove the influence of these factors. As expected electrode location 
and adiposity both had a pronounced influence on voluntary sEMG amplitude. Normalisation 
of these measurements to MMAX peak-to-peak removed the influence of electrode location and 
reduced, but did not consistently remove the influence of subcutaneous adiposity. Thus, 
normalization to MMAX peak-to-peak may help to reduce the influence of these potential 
confounding factors when comparing measurements within- or between-participants in clinical 
assessments or research studies. However, to fully remove the influence of adipose tissue 
thickness may require direct measurements of this parameter beneath the recording electrodes.  
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Figure Legends 
 
Fig. 1 - Electrode placement over the vastus lateralis (VL) for Experiment one (Spatial 
Location). Anterior (A) and posterior (P) rows of electrodes were placed at ~30% and ~70% 
of the distance between the superficial anterior and posterior borders of the VL (respectively) 
and numbered from distal to proximal. 
Fig. 2 - An example ultrasound image from one participant for the measurement of muscle 
electrode distance (MED) in Experiment two. Measurement of MED over the vastus lateralis 
(VL) at 60% of the thigh length. 
Fig. 3 - Experiment one – Spatial location. Absolute sEMG measurements from 6 recording 
sites over the surface of the vastus lateralis (VL) during maximum voluntary torque production 
(EMGMVT, A) and during MMAX responses [B, peak-to-peak (P-P); and C, area]. Mean values 
are shown for n=10. Post-hoc differences between sites are indicated as: * higher than P2 and 
P3 (P≤0.036), ≠ higher than P3 (P≤0.046), § higher than P2 (P≤0.041). 
Fig. 4 - Experiment one – Electrode spatial location. EMGMVT (surface EMG at maximum 
voluntary torque) normalized to (A) MMAX peak-to-peak (P-P) or (B) MMAX Area for 6 
recording sites over the surface of the vastus lateralis. Mean values are shown for n=10. Post-
hoc differences between sites are indicated as: # higher than P3 (P≤0.014). 
Fig. 5 - Experiment two – muscle-electrode distance (n=41). Relationship between muscle-
electrode distance (MED) and three different measures of surface EMG amplitude during 
maximum voluntary torque (MVT) production: A, absolute EMGMVT; B, EMGMVT normalized 
to MMAX peak-to-peak (P-P); C, EMGMVT normalized to MMAX Area; for individual muscles 
[rectus femoris (RF); vastus medialis (VM); and vastus lateralis (VL); n=41]. 
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Table 1 – surface EMG recorded at the six sites over the vastus lateralis (VL) during isometric knee extension maximum 
voluntary torque (MVT) production (absolute and normalized to MMAX Area and peak-to-peak [P-P]), and absolute evoked MMAX 
responses (MMAX Area and P-P). Data are mean ± SD (n=10). 
VL Sites EMGMVT MMAX Area MMAX P-P Normalized EMGMVT Normalized EMGMVT 
 (mV) (mV.s) (mV) (MMAX Area.s-1)  (%MMAX P-P) 
A1 0.22 ± 0.06 0.019 ± 0.004 2.8 ± 0.7 12.3 ± 2.2 8.5 ± 2.9 
A2 0.21 ± 0.06 0.018 ± 0.006 2.9 ± 0.9 12.5 ± 3.1 7.7 ± 1.9 
A3 0.22 ± 0.10 0.021 ± 0.009 3.0 ± 1.6 11.7 ± 6.3 8.7 ± 4.8 
P1 0.18 ± 0.05 0.014 ± 0.004 2.3 ± 0.7 13.8 ± 2.3 8.3 ± 1.8 
P2 0.14 ± 0.03 0.010 ± 0.003 1.4 ± 0.3 13.5 ± 4.1 9.8 ± 2.4 
P3 0.13 ± 0.03 0.015 ± 0.004 1.9 ± 0.7 8.8 ± 3.9 7.6 ± 4.0 
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Table 2 – surface EMG variables recorded over the rectus femoris (RF), vastus medialis (VM) and vastus lateralis (VL) during 
isometric knee extension maximum voluntary torque (MVT) production: absolute EMGMVT; EMGMVT corrected for muscle-
electrode distance (MED); EMGMVT normalized to both MMAX Area and peak-to peak (P-P). Data are mean ± SD (n=41). 
EMG Variables RF CVB (%) VM CVB (%) VL CVB (%) 
       
EMGMVT (mV) 0.17 ± 0.09 51.1 0.22 ± 0.10 44.0 0.15 ± 0.09 62.1 
EMGMVT (mV, corrected for MED) 0.17 ± 0.05 29.6 0.22 ± 0.07 34.2 0.15 ± 0.06 39.5 
Normalized EMGMVT (MMAX Area.s-1) 13.7 ± 4.8 36.2 12.7 ± 5.7 44.4 10.9 ± 4.9 44.2 
Normalized EMGMVT (%MMAX P-P) 9.5 ± 2.9 30.8 8.7 ± 3.5 40.5 8.0 ± 3.1 38.9 
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[Fig. 4] 
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